Connective tissue growth factor and cardiac fibrosis

Area of Science:

• Cardiovascular Biology
• Fibrosis Research
• Molecular Medicine

Background:

• Cardiac fibrosis, characterized by excessive extracellular matrix deposition, is a primary driver of cardiovascular diseases and heart failure.
• Connective tissue growth factor (CTGF) is increasingly recognized for its significant role in fibrotic processes across various tissues, including the heart.
• CTGF acts as a crucial orchestrator of local factors that promote cardiac fibrosis.

Purpose of the Study:

• To elucidate the role of CTGF in the pathogenesis of cardiac fibrosis.
• To investigate CTGF as a potential biomarker for cardiac fibrosis.
• To explore CTGF as a therapeutic target for mitigating cardiac fibrosis.

Main Methods:

• Review of accumulating evidence on CTGF function in cardiac fibrotic processes.
• Analysis of CTGF's role as a matricellular protein in cardiac remodeling.
• Evaluation of CTGF's potential in disease diagnosis and treatment.

Main Results:

• CTGF is central to the fibrotic process in the heart, orchestrating key fibrotic factors.
• The matricellular nature of CTGF positions it as a modulator of cardiac remodeling during fibrosis.
• Evidence supports CTGF's involvement in the development of cardiac dysfunction and heart failure.

Conclusions:

• CTGF is a pivotal factor in cardiac fibrosis development and progression.
• CTGF presents potential as a reliable biomarker for diagnosing cardiac fibrosis.
• Targeting CTGF offers a promising therapeutic strategy to combat cardiac fibrosis and prevent heart failure.